Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 25:16:1611861.
doi: 10.3389/fimmu.2025.1611861. eCollection 2025.

Tracking cellular therapies to optimize homing against liver metastases

Affiliations
Review

Tracking cellular therapies to optimize homing against liver metastases

Megan C Purl et al. Front Immunol. .

Abstract

Novel cellular therapies have shown practice changing results in a range of hematologic malignancies, though success against solid tumors has been limited. Key factors limiting success of these therapies against solid tumors are homing to the site(s) of disease, engraftment, maintenance of function, and persistence. The inhospitable tumor microenvironment appears to provide barriers at every step of this process. The liver, a unique organ with diverse immunoregulatory functions, is a common site for metastatic disease from solid cancers of the gastrointestinal (GI) tract. Although the complex interplay between hepatocytes, circulatory and tissue resident immune cells, and the enterohepatic circulation has been investigated for some time, many unanswered questions about the immunobiology of the liver remain. More so, novel imaging techniques provide unparalleled insight into these interactions and shed light on these complex processes that can lead to an improved understanding of the tumor microenvironment in the liver and opportunities for improving homing of cellular therapy against liver tumors. In this review, we will provide a focused assessment of this burgeoning field and focus on the emerging tools for studying homing of these therapies and how they may be enhanced to better treat liver metastases.

Keywords: cancer immunotherapy; cellular therapy; chimeric antigen receptor; immune cell tracking; liver metastases; regional therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Strategies and techniques to improve cellular therapy for liver metastases of gastrointestinal (GI) origin. These include liver-directed regional therapies, combinations with external beam radiation therapy, augmenting CAR therapy with cytokines, and tracking CAR therapy using modern imaging modalities and novel probes. CAR, chimeric antigen receptor; PET, positron emission tomography; SPECT, single-photon emission computed tomography; CT, computed tomography; MRI, magnetic resonance imaging; US/PA, ultrasound/photoacoustic imaging. Created in BioRender. Purl, M. (2025) https://BioRender.com/4givi1o.

Similar articles

References

    1. Qi C, Liu C, Gong J, Liu D, Wang X, Zhang P, et al. Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results. Nat Med. (2024) 30:2224–34. doi: 10.1038/s41591-024-03037-z - DOI - PubMed
    1. Brodt P. Role of the microenvironment in liver metastasis: from pre- to prometastatic niches. Clin Cancer Res. (2016) 22:5971–82. doi: 10.1158/1078-0432.CCR-16-0460 - DOI - PubMed
    1. Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. (2015) 17:816–26. doi: 10.1038/ncb3169 - DOI - PMC - PubMed
    1. Dey A, Allen J, Hankey-Giblin. PA. Ontogeny and polarization of macrophages in inflammation: blood monocytes versus tissue macrophages. Front Immunol. (2014) 5:683. doi: 10.3389/fimmu.2014.00683 - DOI - PMC - PubMed
    1. Mills CD. Anatomy of a discovery: M1 and M2 macrophages. Front Immunol. (2015) 6:212. doi: 10.3389/fimmu.2015.00212 - DOI - PMC - PubMed

LinkOut - more resources